150 related articles for article (PubMed ID: 16580881)
1. AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma.
Harding TC; Lalani AS; Roberts BN; Yendluri S; Luan B; Koprivnikar KE; Gonzalez-Edick M; Huan-Tu G; Musterer R; VanRoey MJ; Ozawa T; LeCouter RA; Deen D; Dickinson PJ; Jooss K
Mol Ther; 2006 May; 13(5):956-66. PubMed ID: 16580881
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
[TBL] [Abstract][Full Text] [Related]
3. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Isayeva T; Ren C; Ponnazhagan S
Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor.
Mahendra G; Kumar S; Isayeva T; Mahasreshti PJ; Curiel DT; Stockardt CR; Grizzle WE; Alapati V; Singh R; Siegal GP; Meleth S; Ponnazhagan S
Cancer Gene Ther; 2005 Jan; 12(1):26-34. PubMed ID: 15359287
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
6. Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma.
Streck CJ; Zhou J; Ng CY; Zhang Y; Nathwani AC; Davidoff AM
J Am Coll Surg; 2004 Jul; 199(1):78-86. PubMed ID: 15217634
[TBL] [Abstract][Full Text] [Related]
7. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF
Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917
[TBL] [Abstract][Full Text] [Related]
8. Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy.
Gao Y; Ng SS; Chau DH; Yao H; Yang C; Man K; Huang PT; Huang C; Huang JJ; Kung HF; Lin MC
Cancer Gene Ther; 2008 Nov; 15(11):723-32. PubMed ID: 18535618
[TBL] [Abstract][Full Text] [Related]
9. A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide.
Ng SS; Gao Y; Chau DH; Li GH; Lai LH; Huang PT; Huang CF; Huang JJ; Chen YC; Kung HF; Lin MC
Cancer Gene Ther; 2007 Jun; 14(6):561-72. PubMed ID: 17384579
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
[TBL] [Abstract][Full Text] [Related]
11. AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo.
Zacchigna S; Zentilin L; Morini M; Dell'Eva R; Noonan DM; Albini A; Giacca M
Cancer Gene Ther; 2004 Jan; 11(1):73-80. PubMed ID: 14681728
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.
Lin J; Lalani AS; Harding TC; Gonzalez M; Wu WW; Luan B; Tu GH; Koprivnikar K; VanRoey MJ; He Y; Alitalo K; Jooss K
Cancer Res; 2005 Aug; 65(15):6901-9. PubMed ID: 16061674
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models.
Streck CJ; Dickson PV; Ng CY; Zhou J; Gray JT; Nathwani AC; Davidoff AM
Clin Cancer Res; 2005 Aug; 11(16):6020-9. PubMed ID: 16115947
[TBL] [Abstract][Full Text] [Related]
15. Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors.
Harding TC; Dickinson PJ; Roberts BN; Yendluri S; Gonzalez-Edick M; Lecouteur RA; Jooss KU
Hum Gene Ther; 2006 Aug; 17(8):807-20. PubMed ID: 16942441
[TBL] [Abstract][Full Text] [Related]
16. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy.
Lai YK; Shen WY; Brankov M; Lai CM; Constable IJ; Rakoczy PE
Gene Ther; 2002 Jun; 9(12):804-13. PubMed ID: 12040462
[TBL] [Abstract][Full Text] [Related]
17. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
[TBL] [Abstract][Full Text] [Related]
18. Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.
Schmitz V; Vilanueva H; Raskopf E; Hilbert T; Barajas M; Dzienisowicz C; Gorschlüter M; Strehl J; Rabe C; Sauerbruch T; Prieto J; Caselmann WH; Qian C
Gene Ther; 2006 Aug; 13(16):1198-205. PubMed ID: 16617302
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV.
Ho DT; Wykoff-Clary S; Gross CS; Schneider D; Jin F; Kretschmer PJ; Hermiston TW
Cancer Gene Ther; 2009 Feb; 16(2):184-94. PubMed ID: 18758433
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin-regulated control of antiangiogenic tumor therapy following rAAV-mediated gene transfer.
Nguyen M; Huan-Tu G; Gonzalez-Edick M; Rivera VM; Clackson T; Jooss KU; Harding TC
Mol Ther; 2007 May; 15(5):912-20. PubMed ID: 17245354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
